Novavax Historical Cash Flow
| NVAX Stock | USD 8.62 0.13 1.49% |
Analysis of Novavax cash flow over time is an excellent tool to project Novavax future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 61.7 M or Total Cash From Financing Activities of 4.2 M as it is a great indicator of Novavax ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Novavax latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Novavax is a good buy for the upcoming year.
Novavax |
About Novavax Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Novavax balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Novavax's non-liquid assets can be easily converted into cash.
Novavax Cash Flow Chart
Add Fundamental
Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Novavax value has been used up. For tax purposes Novavax can deduct the cost of the tangible assets it purchases as business expenses. However, Novavax must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Novavax's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Novavax current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.At this time, Novavax's Cash And Cash Equivalents Changes is fairly stable compared to the past year. Change To Netincome is likely to rise to about 693.2 M in 2024, despite the fact that Change In Cash is likely to grow to (726.8 M).
Novavax cash flow statement Correlations
Click cells to compare fundamentals
Novavax Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Novavax cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 221K | 566.6M | 879.5M | (179.4M) | (765.0M) | (726.8M) | |
| Free Cash Flow | (138.5M) | (97.2M) | 265.5M | (508.9M) | (772.8M) | (734.1M) | |
| Change In Working Capital | (24.0M) | 12.0M | 1.7B | (361.2M) | (376.8M) | (358.0M) | |
| Begin Period Cash Flow | 82.0M | 82.2M | 648.7M | 1.5B | 1.3B | 1.4B | |
| Other Cashflows From Financing Activities | 992K | 205.2M | 24.8M | (5.9M) | (3.4M) | (3.3M) | |
| Depreciation | 5.7M | 4.9M | 12.7M | 29.1M | 41.2M | 43.3M | |
| Other Non Cash Items | 6.3M | 230.8M | 136.8M | 443.8M | 81.3M | 85.4M | |
| Capital Expenditures | 1.9M | 54.6M | 57.5M | 93.0M | 58.8M | 61.7M | |
| Total Cash From Operating Activities | (136.6M) | (42.5M) | 322.9M | (415.9M) | (714.0M) | (678.3M) | |
| Net Income | (132.7M) | (418.3M) | (1.7B) | (657.9M) | (545.1M) | (517.8M) | |
| Total Cash From Financing Activities | 98.4M | 984.8M | 461.7M | 325.0M | 4.5M | 4.2M | |
| End Period Cash Flow | 82.2M | 648.7M | 1.5B | 1.3B | 583.8M | 613.0M | |
| Sale Purchase Of Stock | 102.8M | 98.4M | (39.1M) | 589.6M | 678.1M | 712.0M | |
| Change To Account Receivables | (4.2M) | (422.7M) | (192.3M) | 249.2M | (274.4M) | (260.7M) | |
| Change To Liabilities | (19.8M) | 434.7M | 1.9B | (132.5M) | (152.4M) | (144.8M) | |
| Stock Based Compensation | 17.0M | 128.0M | 183.6M | 130.3M | 85.4M | 89.6M | |
| Total Cashflows From Investing Activities | 38.5M | (377.8M) | 100.2M | (93.0M) | (83.7M) | (79.5M) | |
| Investments | 22.0M | (157.6M) | 157.6M | (93.0M) | (71.8M) | (68.2M) | |
| Cash And Cash Equivalents Changes | (53.4M) | 253K | 564.4M | 884.8M | 1.0B | 1.1B | |
| Cash Flows Other Operating | 1.2M | (4.2M) | (422.7M) | (192.3M) | (173.0M) | (164.4M) | |
| Change To Netincome | 13.0M | 111.5M | 176.0M | 574.1M | 660.2M | 693.2M | |
| Issuance Of Capital Stock | 97.4M | 1.1B | 564.9M | 249.2M | 326.8M | 442.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.